Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer

Published:2010-02-25 Issue:4 Volume:36 Page:885-892
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:European Respiratory Journal

Author:

Kumar S.,Guleria R.,Singh V.,Bharti A. C.,Mohan A.,Das B. C.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses;Exploration of Targeted Anti-tumor Therapy;2024-05-28

2. Can cell‐free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I−III a nonsmall cell lung cancer (NSCLC)? A pilot study;Journal of Surgical Oncology;2024-03-04

3. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation;International Journal of Molecular Sciences;2023-08-25

4. Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study;Cancers;2022-12-06

5. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer;Scientific Reports;2022-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP